Article
type: Class

Document
type: Class

Anualidad
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

2020
type: Class

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

RDF description of Tocilizumab Treatment for Nephrotic Syndrome Due to Amyloidosis in Behcets Disease - http://research.umh.es/vivo/pub/articulo/218894
type: Document
rights: termsOfUse
date: 2026-08-30T03:21:02
publisher: Tocilizumab Treatment for Nephrotic Syndrome Due to Amyloidosis in Behcets Disease

Tocilizumab Treatment for Nephrotic Syndrome Due to Amyloidosis in Behcets Disease
type: 2020
type: Thing
has publication venue: RENAL FAILURE
page end: 550
type: Information Content Entity
type: Article
included: Medicina Clínica 2020
type: Generically Dependent Continuant
type: Academic Article
related by: Autor:162158-Artículo:218894
most specific type: Academic Article
ARG_2000028: 218894 vcard
type: Continuant
most specific type: 2020
type: Document
page start: 547
type: Anualidad
date time value: 218894 pubdate
type: Entity

RENAL FAILURE
type: Entity
type: Journal
type: Continuant
type: Thing
type: Generically Dependent Continuant
type: Periodical
publication venue for: Tocilizumab Treatment for Nephrotic Syndrome Due to Amyloidosis in Behcets Disease
type: Information Content Entity
type: Collection

Medicina Clínica 2020
type: Anualidad
type: 2020
type: DepartmentReport
type: Thing
type: ResearchReport
includes: Tocilizumab Treatment for Nephrotic Syndrome Due to Amyloidosis in Behcets Disease

Autor:162158-Artículo:218894
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Tocilizumab Treatment for Nephrotic Syndrome Due to Amyloidosis in Behcets Disease